PI’s Google Scholar profile, ScopusID: 14632352500, OrcidID 0000-0002-4051-022X, ResearcherID H-4397-2011, ResearchGate profile; >3000 citations; H-index =28 (starting 2006).

PI’s internationally peer-reviewed and (except one) Pubmed-indexed N=62; exclusive of conference abstracts, proceedings or pre-prints (please click titles for pdf download):

Castro Santos H; Rodrigues A, Ferreira S, Malhadas Martins M, Baptista T, Gama Marques J, Kirkpatrick B, PRATA D. The European Portuguese version of the Brief Negative Symptom Scale. Psychopathology. In press.

Cosme G, Arriaga P, Rosa PJ, Mehta M, PRATA D. Temporal profile of intranasal oxytocin in the human autonomic nervous system at rest: an electrocardiography and pupillometry study. Journal of Psychopharmacology. 2023. 2698811231158233. doi:10.1177/02698811231158233

Cogoni C, Fiuza A, Hassanein L, Antunes M, PRATA D. Computer anthropomorphisation in a socio-economic dilemma. Behavior Research Methods. 2023. 10.3758/s13428-023-02071-y. doi:10.3758/s13428-023-02071-y

Tavares V, Vassos E, Marquand A, Stone J, Valli I, Barker GJ, Ferreira HA, PRATA D. Prediction of transition to psychosis from an at-risk mental state using structural neuroimaging, genetic and environmental data. Frontiers in Psychiatry. 2023. Volume 13.

PRATA D, Silva M. Neuroimaging genetics of oxytocin: a transcriptomics-informed systematic review. Neuroscience and Biobehavioral Reviews. 2022. 142 – 104912

Vouga Ribeiro N, Tavares V, Bramon E, Toulopoulou T, Valli I, Shergill S, Murray R, PRATA D. Effects of psychosis-associated genetic markers on brain volumetry: A systematic review of replicated findings and an independent validation. Psychological Medicine. 2022. 1-16.

Diogo V, Ferreira HA*, PRATA D*. Early diagnosis of Alzheimer’s disease using machine learning: a multi-diagnostic, generalizable approach. Alzheimer’s Research and Therapy. 2022. 14 (1), 1-21. *Equal contribution

Zelenina M*, Kosilo M*, da Cruz J, Antunes M, Figueiredo P, Mehta MA, PRATA D. Temporal dynamics of intranasal oxytocin in human brain electrophysiology. Cerebral Cortex. 2022. 32(14): 3110-3126. *Equal contribution

Kosilo M, Costa M, Nuttall H, Ferreira H, Scott S, Meneres S, Pestana J, Jerónimo R, PRATA D. The neural basis of authenticity recognition in laughter and crying. Scientific Reports (Nature Research). 2021. 11 (1), 1-13.

Tavares V, Monteiro J, Vassos E, Coleman J, PRATA D. Evaluation of genotype-based gene expression model performance: a cross-framework and cross-dataset study. Genes. 2021. 12(10), 1531.

Blest-Hopley G, Colizzi M, PRATA D, Giampietro V, Brammer M, McGuire P, Bhattacharyya S. Epigenetic mediation of AKT1 rs1130233’s effect on delta-9-tetrahydrocannabinol-induced medial temporal function during fear processing. Brain Sciences. 2021. 11 (9), 1240.

Tavares V, Fernandes L, Antunes M, Ferreira H*, PRATA D*. Sex differences in functional connectivity between resting-state brain networks in autism spectrum disorder. Journal of Autism and Developmental Disorders. 2021. 52 (7), 3088-3101. *Equal contribution.

Cosme G*, Tavares V*, Nobre G, Lima C, Sá R, Rosa P, PRATA D. Cultural differences in vocal emotion recognition: A behavioural and skin conductance study in Portugal and Guinea-Bissau. Psychological Research. 2021. DOI: 10.1007/s00426-021-01498-2. *Equal contribution.

Cosme G, Rosa PJ, Lima CF, Tavares V, Scott S, Chen S, Wilcockson TDW, Crawford TJ, PRATA D. Pupil dilation reflects the authenticity of received nonverbal vocalizations. Scientific Reports (Nature Research). 2021. 11(1):3733.

Thygesen JH, Presman A, Harju-Seppänen J, Irizar H, Jones R, Kuchenbaecker K, Lin K, Alizadeh BZ, Austin-Zimmerman I, Bartels-Velthuis A, Bhat A, Bruggeman R, Cahn W, Calafato S, Crespo-Facorro B, de Haan L, de Zwarte SMC, Di Forti M, Díez-Revuelta Á, Hall J, Hall MH, Iyegbe C, Jablensky A, Kahn R, Kalaydjieva L, Kravariti E, Lawrie S, Luykx JJ, Mata I, McDonald C, McIntosh AM, McQuillin A, Muir R, Ophoff R, Picchioni M, PRATA DP, Ranlund S, Rujescu D, Rutten BPF, Schulze K, Shaikh M, Schirmbeck F, Simons CJP, Toulopoulou T, van Amelsvoort T, van Haren N, van Os J, van Winkel R, Vassos E, Walshe M, Weisbrod M, Zartaloudi E, Bell V, Powell J, Lewis CM, Murray RM, Bramon E. Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study. Molecular Psychiatry (Nature Research). 2020. 26 (9), 5307-5319. IF: 11.5

Neto ML, Antunes M, Lopes M, Ferreira D, Rilling J, PRATA D. Oxytocin and vasopressin modulation of Prisoner’s Dilemma strategies. Journal of Psychopharmacology. 2020. 34 (8): 891-900.

Tavares V, Ferreira H*, PRATA D*. Comparing SPM12 and CAT12 segmentation pipelines: a brain tissue volume-based age and Alzheimer’s disease study. Journal of Neuroscience Methods. *Equal contribution. 2020. 334: 108565.

Simões B, Vassos E , Shergill S , McDonald C,  Toulopoulou T , Kalidindi S, Kane K , Murray R, Bramon E, Ferreira H, PRATA D. Schizophrenia polygenic risk score influence on white matter microstructure. Journal of Psychiatric Research. 2020. 121:62-67.

Dos Santos JMP, Ferreira H, Reis J, PRATA D, Simões SP, Borges ID. The Use of Consumer Neuroscience Knowledge in Improving Real Promotional Media: The Case of Worten. Marketing and Smart Technologies. 2020. 202-218.

PRATA D, Cosme G*, Costa-Neves B*, Vassos E. Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: a systematic review. Journal of Psychiatric Research. *Equal contribution. 2019. 114:178-207.

Tecelão D, Mendes A, Martins D, Fu C, Chaddock C, Picchioni M, McDonald C, Kalidindi S, Murray R, PRATA D. The effect of psychosis associated CACNA1C, and its epistasis with ZNF804A, on brain function. Genes Brain and Behaviour. 2019. 18 (4).

Dahoun T, Pardiñas A, Veronese M, Bloomfield M, Jauhar S, Bonoldi I, Froudist-Walsh S, Nosarti C, Korth C, Hennah W, Walters J, Howes O*, PRATA D*.  The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study. Human Molecular Genetics. *Equal contribution. 2018. 27(20):3498-3506.  IF: 5.3.

Torres N*, Martins D*, Santos A, Veríssimo M**, PRATA D**. How do hypothalamic nonapeptides shape youth’s sociality? A systematic review on oxytocin, vasopressin and human socio-emotional development. Neuroscience & Biobehavioral Reviews.  *,**Equal contribution. 2018. 90:309-331 IF: 8.3.

Tecelao D, Mendes A, Martins D, Bramon E, Toulopoulou T, Kravariti E, Murray R, PRATA D. The impact of psychosis genome-wide associated ZNF804A variation on verbal fluency connectivity. Journal of Psychiatric Research. 2018. 98:17-21.

Ranlund S, Calafato S, Thygesen JH, Lin K, Cahn W, Crespo-Facorro B, de Zwarte SMC, Díez Á, Di Forti M; GROUP, Iyegbe C, Jablensky A, Jones R, Hall MH, Kahn R, Kalaydjieva L, Kravariti E, McDonald C, McIntosh AM, McQuillin A, PEIC, Picchioni M, PRATA DP, Rujescu D, Schulze K, Shaikh M, Toulopoulou T, van Haren N, van Os J, Vassos E, Walshe M; WTCCC, Lewis C, Murray RM, Powell J, Bramon E. A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains. Am J Med Genet B Neuropsychiatr Genet. 2017.

Martins D, Mehta M, PRATA D. The “highs and lows” of the brain on dopaminergics: Evidence from neuropharmacology studies in humans. Neuroscience & Biobehavioral Reviews. 2017. 80:51-371. IF: 8.3

Mallas E; Carletti F; Chaddock C; Shergill S; Woolley J; Picchioni M; McDonald C; Toulopoulou T; Kravariti E; Bramon E; Murray R; Barker G; PRATA D. The impact of CACNA1C gene, and its epistasis with ZNF804A, on white matter microstructure in health, schizophrenia and bipolar disorder. Genes, Brain and Behaviour. 2017. 16 (4): 479–488. 

Vassos E, Di Forti M, Coleman J, Iyegbe C, PRATA D, Euesden J, O’Reilly P, Curtis C, Kolliakou A Patel H, Newhouse S, Traylor M, Ajnakina O; Mondelli V, Reis-Marques T, Gardner-Sood P, Aitchison K, Powell J, Atakan Z, Greenwood K, Smith S, Ismail K, Pariante C, Gaughran F, Dazzan P, Markus H; David A; Lewis C; Murray R, Breen G. An examination of polygenic score risk prediction in individuals with first episode psychosis. Biological Psychiatry. Priority Communication. 2017. 8 (6): 470-477. IF:10.2

Martins D, Paloyelis Y, PRATA D. “Shedding light on a dark question”: Peripheral oxytocin signalling and neurobehavioral responses to intranasal oxytocin in humans. Psychoneuroendocrinology. 2016. 73: 271–272

Mallas E, Carletti F, Chaddock C, Woolley J, Picchioni MM, Shergill S, Kane F, Allin M, Barker GJ, PRATA DPGenome-wide discovered psychosis-risk gene ZNF804A impacts on white matter microstructure in health, schizophrenia and bipolar disorder. PeerJ. 2016. 4:e1570; DOI 10.7717/peerj.1570.

Bianconi F, Bonomo M, Marconi A, Kolliakou A, Stilo S, Iyegbe C, Muñoz P, Homayoun S, Mondelli V, Luzi S, Dazzan P, PRATA D, La Cascia C, O’Connor J, David A, Morgan C, Murray R, Lynskey M, Di Forti M. Differences in Cannabis-related Experiences between Patients with a First Episode of Psychosis and Controls. Psychological Medicine.  2016. 16:1-9. IF:5.9

Gurung R & PRATA DPWhat is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review. Psychological Medicine. 2015. 10:1-20. IF:5.9

Mechelli A, PRATA D, Kefford C, Kapur S. Predicting clinical response in people at ultra-high risk for psychosis: A systematic and quantitative review.Drug Discovery Today. 2015. 20(8):924-7. IF:5.9.

Ajnakina O, Borges S, DiForti M, Patel Y, Xu X, Green P, Ciufolini S, Paparelli A, Stilo S, Kolliakou A, Sood P, Marques TR, Sainz-Fuertes R, David AS, PRATA DP, Mondelli V, Dazzan P, Powell J, Pariante C, Morgan C, Murray RM, Fisher HL, Iyegbe C. Role of Environmental Confounding in the Association between FKBP5and First-Episode Psychosis. Frontiers in Psychiatry. 2014. 17;5:84.

PRATA DP, Mechelli A, Kapur S. Clinically meaningful biomarkers for psychosis: a systematic and quantitative review. Neuroscience and Biobehavioural Reviews. 2014. 45:134-41. IF:9.4

Di Forti M, Sallis H, Allegri F, Trotta A, Ferraro L, Stilo S, Marconi A, La Cascia C, Reis-Marques T, Pariante C, Dazzan P, Mondelli V, Paparelli A, Kolliakou A, PRATA D, Gaugrhan F, David AS, Morgan C, Sthal D, Khondoker M, MaCabe R, Murray R. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophrenia Bulletin.2014. 40(6):1509-17. IF:8.5

Bhattacharyya S, Iyegbe C, Atakan Z, Martin-Santos R, Crippa JA, Xu X, MD2, Williams S, Brammer M, Rubia K, PRATA D, Collier DA, McGuire PK. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control. Psychological Medicine. 2014. 44(15):3315-28. IF:5.6

Pettersson-Yeo W, Benetti S, Marquand AF, Dell’acqua F, Williams SC, Allen P, PRATA D, McGuire P, Mechelli A. Using genetic, cognitive and multi-modal neuroimaging data to identify ultra-high-risk and first-episode psychosis at the individual level. Psychological Medicine. 2013. 43(12):2547-62. IF: 6.2

Modinos G, Iyegbe C, PRATA D, Rivera M, Kempton M, Valmaggia L, Sham P, van Os J, McGuire P. Molecular genetic gene–environment studies using candidate genes in schizophrenia: A systematic review. Schizophrenia Research. 2013150 (2-3): 356-65.

PRATA DP, Kanaan KA, Barker GJ, Shergill S, Woolley J, Georgieva L, Picchioni MM, Kravariti E, Walshe M, Allin M, Toulopoulou T, Bramon E, McDonald C, Giampietro V, Murray RM, Brammer M, O’Donovan M, McGuire PK. Risk variant of oligodendrocyte lineage transcription factor 2 is associated with reduced white matter integrity. Human Brain Mapping. 2013. 34 (9):2015-31. IF: 7.1

Pauli A, PRATA DP, Mechelli A, Picchioni M, Fu CHY, Chaddock C, Kane F, Kalidindi S, McDonald C, Kravariti E, Toulopoulou T, Bramon E, Walshe M, Ehlert N, Georgiades A, Murray R, Collier D, McGuire P. Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function. Human Brain Mapping. 2013. 34 (9): 2244-58. IF: 7.1

Radua J, Surguladze SA, Marshall N, Walshe M, Bramon E, Collier DA, PRATA DP, Murray RM, McDonald C. The impact of CACNA1C allelic variation on effective connectivity during emotional processing in bipolar disorder. Molecular Psychiatry (Nature Research). 2013; 18 (5): 526-7 IF: 14.0

Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, Kambeitz J, PRATA D, Williams S, Brammer M, Collier DA, McGuire PK: Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: A preliminary report of the modulation of the effects of delta-9-THC on midbrain and striatal function by AKT1 and DAT1 genotypes. Molecular Psychiatry (Nature Research)2012; 17 (12):1152-5. IF: 14.0

PRATA DP, Gafoor R, Kay V, Arranz M, Munro J, McGuire P. Dopaminergic genes influence early response to atypical antipsychotics in patients with first presentation of psychosis. Journal of Clinical Psychopharmacology. 2012;32(4):566-569.

Mechelli A, PRATA D, Papagni SA, Tognin S, Kambeitz J, Fu C, Picchioni M, Walshe M, Toulopoulou T, Bramon E, Murray R, McGuire P. Genetic vulnerability to psychosis and cortical function: epistatic effects between DAAO and G72. Current Pharmaceutical Design2012;18(4):510-7.

PRATA DP, Mechelli A, Fu C, Picchioni M, Kane F, Kalidindi S, McDonald C, Kravariti E, Toulopoulou T, Bramon E, Walshe M, Murray R, Collier DA, McGuire PK. Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency. Human Brain Mapping2012; 33(1):143-153. IF: 7.1

Papagni S, Mechelli A, PRATA DP, Kambeitz J; Fu HY C, Picchioni M, Walshe M, Toulopoulou T, Bramon E, Murray R, Collier DA, Bellomo A, McGuire P. Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls. Neuroimage2011; 56(4):2283-2291. IF: 6.7

PRATA DP, Mechelli A, Picchioni M, Fu C, Kane F, Kalidindi S, McDonald C, Kravariti E, Toulopoulou T, Bramon E, Walshe M, Murray R, Collier DA, McGuire PK. No association of Disrupted-in-Schizophrenia-1 variation with prefrontal function in patients with schizophrenia and bipolar disorder. Genes, Brain and Behaviour. 2011; 10(3):276-285

Costafreda SG, Fu CH, Picchioni M, Toulopoulou T, McDonald C, Kravariti E, Walshe M, PRATA D, Murray RM, McGuire PK. Pattern of neural responses to verbal fluency shows diagnostic specificity for schizophrenia and bipolar disorder.BioMed Central Psychiatry2011;11: No.18.

Baharnoori M, Bartholomeusz C, Boucher AA, Buchy L, Chaddock C, Chiliza B, Föcking M, Fornito A, Gallego JA, Hori H, Huf G, Jabbar GA, Kang SH, El Kissi Y, Merchán-Naranjo J, Modinos G, Abdel-Fadeel NA, Neubeck AK, Ng HP, Novak G, Owolabi OO, PRATA DP, Rao NP, Riecansky I, Smith DC, Souza RP, Thienel R, Trotman HD, Uchida H, Woodberry KA, O’Shea A, Delisi LE. The 2nd Schizophrenia International Research Society Conference, 10-14 Apr 2010, Florence, Italy: Summaries of oral sessions. Schizophrenia Research. 2010; 124 (1-3):e1-e62. IF: 5.0

PRATA DP, Mechelli A, Picchioni M, Fu C, Toulopoulou T, Bramon E, Walshe M, Murray R, Collier DA, McGuire. Altered effect of dopamine transporter 3’UTR VNTR genotype on prefrontal and striatal function in schizophrenia. Archives of General Psychiatry. 2009; 66(11):1162-72. IF: 16.5

Dutt A, McDonald C, Dempster E, PRATA D, Shaikh M, Williams I, Schulze K, Marshall N, Walshe M, Allin M, Collier D, Murray R, Bramon. The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychological Medicine. 2009;39(11):1783-97. IF: 5.5

Costafreda SG, Fu CH, Picchioni M, Kane F, McDonald C, PRATA DP, Kalidindi S, Walshe M, Curtis V, Bramon E, Kravariti E, Marshall N, Toulopoulou T, Barker GJ, David AS, Brammer MJ, Murray RM, McGuire PK. Increased inferior frontal activation during word generation: A marker of genetic risk for schizophrenia but not bipolar disorder? Human Brain Mapping. 2009;30(10):3287-98. IF: 7.1

PRATA DP, Mechelli A, Fu C, Picchioni M, Toulopoulou T, Bramon E, Walshe M, Murray R, Collier DA, McGuire. Epistasis between the DAT 3’UTR VNTR and COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophreniaProceedings of the National Academy of Sciences of the United States of America (PNAS).2009;106(32):13600-5. IF: 10.4

Mechelli A, Tognin S, McGuire PK, PRATA D, Sartori G, Fusar-Poli P, De Brito S, Hariri AR, Viding E. Genetic Vulnerability to Affective Psychopathology in Childhood: A Combined Voxel-Based Morphometry and Functional Magnetic Resonance Imaging Study. Biological Psychiatry. 2009; 66(3): 231-237. IF: 10

PRATA DP, Breen G, Osborne S, Munro J, St. Clair D and Collier DA. An association study of the Neuregulin 1 gene, Bipolar Affective Disorder and Psychosis. Psychiatric Genetics2009;19(3):113-6.

PRATA DP, Mechelli A, Fu C, Picchioni M, Kane F, Kalidindi S, McDonald C, Howes O, Kravariti E, Demjaha A, Toulopoulou T, Diforti M, Murray R, Collier DA, McGuire. Opposite effects of COMT Val158Met on cortical function in healthy subjects and patients with SchizophreniaBiological Psychiatry. 2009;65(6):473-80. IF: 9.5

PRATA DP, Mechelli A, Fu C, Picchioni M, Kane F, Kalidindi S, McDonald C, Kravariti E, Toulopoulou T, Miorelli A, Murray R, Collier DA, McGuire. Effect of disrupted-in-schizophrenia-1 on pre-frontal cortical function. Molecular Psychiatry(Nature Research)2008 Oct 13(10): 915-917 – which was featured as IMAGE in Molecular Psychiatry. 2008;13(10):909. IF: 14.0

PRATA D, Breen G, Osborne S, Munro J, St. Clair D and Collier DA. Association of DAO and G72(DAOA)/G30 genes with Bipolar Affective Disorder. American Journal of Medical Genetics- Part B (Neuropsychiatric Genetics). 2008;147B(6):914-7.

Mechelli A, PRATA DP, Fu CH, Picchioni M, Kane F, Kalidindi S, McDonald C, Demjaha A, Kravariti E, Toulopoulou T, Murray R, Collier DA, McGuire PK. The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. Neuroimage. 2008;42(2):817-26. IF: 6.9

PRATA DP, Breen G, Munro J, Sinclair M, Osborne S, Li T, Kerwin R, St Clair D, Collier DA. Bipolar 1 Disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes. Psychiatric Genetics. 2006;16(6):229-30.

PRATA D*, Breen G*, Osborne S, Munro J, Sinclair M, Li T, Staddon S, Dempster D, Sainz R, Arroyo B, Kerwin RW, St Clair D, Collier DA. Association of the Dysbindin gene with Bipolar Affective Disorder. American Journal of Psychiatry2006;163(9):1636-8.* Equal contribution. IF: 14.4


Book Chapters

Martins D & PRATA DP. Is depression in our genes? [PT] In A promoção da saúde mental e a prevenção da depressão e suicídio: foco estratégico na integração da saúde mental nos cuidados de saúde primários. EUTIMIA, Lisboa. In press.

Martins D & PRATA DP. Is suicide in our genes? [PT] In A promoção da saúde mental e a prevenção da depressão e suicídio: foco estratégico na integração da saúde mental nos cuidados de saúde primários. EUTIMIA, Lisboa. In press.

Martins D & PRATA DP. A depressed brain? [PT] In A promoção da saúde mental e a prevenção da depressão e suicídio: foco estratégico na integração da saúde mental nos cuidados de saúde primários. EUTIMIA, Lisboa. In press.

E-Research Methods Working Group. E-Research Methods (online material). 2014. King’s College London. UK.

PRATA DP2014Biological basis of schizophrenia. In II Congresso de Reabilitação e Inclusão na Saúde Mental (Congress on rehabilitation and inclusion in Mental Health). University of Coimbra, Portugal.

PRATA DP. 2014Biological basis of cognition in schizophrenia. In II Congresso de Reabilitação e Inclusão na Saúde Mental (Congress on rehabilitation and inclusion in Mental Health). University of Coimbra, Portugal.

PRATA DP. 2008. Effect of Dopamine Regulating Genes on Regional Brain Function during Verbal Fluency in Controls and in Patients with Schizophrenia. PhD Thesis. King’s College London. UK.

UntitledUntitled 31Untitled 29Untitled 28Untitled 27Untitled 26Untitled 25Untitled 24Untitled 23Untitled 22Untitled 21Untitled 20Untitled 19Untitled 18Untitled 17Untitled 16Untitled 15Untitled 14Untitled 13Untitled 12Untitled 11Untitled 10Untitled 9Untitled 8Untitled 6Untitled 5Untitled 4Untitled 3Untitled 2Untitled 1Untitled 32Untitled